GlassScriptPhysician profile
Jennifer B Cox
NPI 1609843242
$2,165.37
in general payments reported to CMS, 2019-2025
14 companies · $345 in 2025
The $345 reported for 2025 was more than what 87% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.42 · 2020: $26.04 · 2021: $220 · 2022: $233 · 2023: $500 · 2024: $747 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586 · Education: $6.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.84 |
| Education | $6.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $579.63 | 2021-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $360.26 | 2019-2025 | Vaxneuvance, Rotateq, Gardasil 9 |
| Pfizer INC. | $260.27 | 2022-2025 | |
| Cranial Technologies, INC | $222.83 | 2021-2024 | Doc Band |
| Corium, LLC | $168.88 | 2023-2025 | Azstarys |
| Kaleo, INC. | $137.43 | 2021-2023 | Auvi-Q |
| Sanofi Pasteur INC. | $101.74 | 2019-2025 | |
| Tris Pharma INC | $85.06 | 2022-2024 | Dyanavel Xr |
| Vertical Pharmaceuticals, LLC | $65.52 | 2024-2025 | Relexxii |
| Ironshore Pharmaceuticals INC. | $64.87 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $64.39 | 2025 | Jornay Pm |
| Sobi, INC | $24.64 | 2023 | |
| Shire North American Group INC | $17.90 | 2019 | |
| Adlon Therapeutics L.P. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.